Filters
Ulibro(R) Breezhaler(R) - dual bronchodilatacion by fixed combination of indacaterol/glycopyrronium in treatment of chronic obstructive lung disease
Present work describes she role of long acting beta agonists (LABA) and anticholinergics (LAMA) in a fixed combination in patients with chronic obstructive lung disease (COPD). The first medicament - dual bronchodilatator with indacaberol and gly...
FC - Pneumologie
- 2014 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Efficacy of dual bronchodilator therapy (indacaterol / glycopyrronium) to reduce pulmonary hyperinflation and subsequently improve chamber filling in patients with COPD
This commentary discusses the various aspects and benefits of the newly published CLAIM study (the effectiveness of dual bronchodilator treatment - indicatrol / glycopyrronium - to reduce pulmonary hyperinflation and consequently improve car...
Respiratory systems
- 2018 •
- Jost
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Fixed-dose dual bronchodilation - a new treatment option for chronic obstructive pulmonary disease
Dual bronchodilation with a long-acting anticholinergic and beta-2 agonist administered as a single agent represents a new option for treating patients with chronic obstructive pulmonary disease. The studies mentioned in the article confirmed high ef...
FC - Pneumologie
- 2014 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD-A Cost-Effectiveness Analysis in the Czech Republic
Background: Chronic obstructive pulmonary disease (COPD) represents an illness with significant healthcare and societal impacts. Fixed combinations of long-acting beta-agonists (LABA) and inhaled corticosteroids have been used for COPD treatment as t...
Pharmacology and pharmacy
- 2018 •
- JSC •
- Link
Rok uplatnění
JSC - Článek v periodiku v databázi SCOPUS
Výsledek na webu
Dual bronchodilation - a new approach in the treatment of COPD
. The dual combination of ultra-long acting beta2-mimetic indacaterol and a new anticholinergic glycopyrronium bromide is being referred to QVA 149 so far (registered of exacerbations compared with glycopyrronium or tiotrop...
FC - Pneumologie
- 2014 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Indacaterol vs. tiotropium in the treatment of chronic obstructive pulmonary disease - studies Intensity
In a study of the intensity were observed bronchodilator same effects of indacaterol rated by spirometry and tritropia. However, indacaterol demonstrated in clinical prarametrů better results, and thus extends the influence of sympt...
FC - Pneumologie
- 2012 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Efficacy and safety of glycopyrronium bromide in patients with chronic obstructive pulmonary disease - results of GLOW1-3 studies
Registrations studies of the new bronchodilatation drug - glycopyrronium bromide are present. The effects in chronic obstructive pulmonary disease are characterized....
FC - Pneumologie
- 2013 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Effectiveness of indacaterol from the perspective of COPD patients
For treating patients with COPD, indacaterol, a novel drug from the group of long-lasting beta2-agonists, was introduced into clinical practice. The article summarizes results of published studies to discuss effectiveness of the drug as subj...
FC - Pneumologie
- 2012 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Glycopyrronium bromide - a new anticholinergic agent for the treatment of chronic obstructive pulmonary disease
and M3 .The already known anticholinergic increasing new drug glycopyrronium bromide hours , glycopyrronium for 5-15 minutes. 28 9th 2012 has been a new drug glycopyrronium bromide centrally authorized in the European Unio...
FC - Pneumologie
- 2013 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Tolerability of indacaterol, a novel once-daily beta(2)-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study
Randomised placebo controlled study of safety of indacaterol, a novel long-acting beta-2 agonist.
FC - Pneumologie
- 2007 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
- 1 - 10 out of 15